Oramed Pharmaceuticals Inc.
2 Elza Street
Jerusalem
93706
Tel: 011-972-54-7909058
Fax: 011-972-2-6792336
Website: http://www.oramedpharma.com/
Email: info@oramedpharma.com
324 articles about Oramed Pharmaceuticals Inc.
-
Oramed Pharmaceuticals Inc. Reports Positive Top-Line Data From U.S. Phase 2a Trial With Oral Insulin In Type 1 Diabetes
10/22/2014
-
Oramed Pharmaceuticals Inc. To Present At Upcoming Conferences
9/5/2014
-
Oramed Pharmaceuticals Inc. Granted Patent in Spain For Oral Administration Of Insulin
8/19/2014
-
Oramed Pharmaceuticals Inc. Reports Last Patient Out In Phase Iia Trial For ORMD-0801 In Type 1 Diabetes
8/7/2014
-
Oramed Pharmaceuticals Inc. To Present At The Biotechnology Industry Organization (BIO) International Convention In San Diego
6/23/2014
-
Oramed Pharmaceuticals Inc. To Present At The American Diabetes Association 74th Scientific Sessions On June 13 - 17, 2014 In San Francisco
6/10/2014
-
Oramed Pharmaceuticals Inc. To Present At Jefferies and Co. Global Healthcare Conference On June 2 In New York City
5/27/2014
-
Oramed Pharmaceuticals Inc. To Present At The IATI Israel Innovation Conference In Tel Aviv
5/19/2014
-
Oramed Pharmaceuticals Inc. To Present Poster On Its Oral Insulin Capsule At The Yale Diabetes Symposium
5/13/2014
-
Oramed Pharmaceuticals Inc. Presents Data From Phase Iia Trial With ORMD-0801 In Type 2 Diabetes At The 2014 Diabetes Summit
4/25/2014
-
Oramed Pharmaceuticals Inc. Granted Patent In Hong Kong For Oral Administration Of Insulin
4/10/2014
-
LifeSci Advisors Initiates Coverage Of Oramed Pharmaceuticals Inc.
3/21/2014
-
Oramed Pharmaceuticals Inc. to Present At Upcoming Conferences
3/6/2014
-
Oramed Pharmaceuticals Inc. To Present Results From Its Phase 2a FDA Trial With ORMD-0801 At The 2014 Diabetes Summit On April 24, 2014
3/3/2014
-
Oramed Pharmaceuticals Inc. Submits Phase 2a Protocol To FDA For The Treatment Of Type 1 Diabetes With Its Oral Insulin Capsule
2/10/2014
-
Oramed Pharmaceuticals Inc. Announces Successful FDA Phase 2a Clinical Trial Results
1/30/2014
-
Oramed Pharmaceuticals Inc. Receives Patent Allowance In Israel And Australia For Platform Technology In Oral Delivery Of Proteins
1/2/2014
-
Oramed Pharmaceuticals Inc. Nets $15.8 Million In Direct Offering To Investors
12/27/2013
-
Oramed Pharmaceuticals Inc. Announces Successful Results From Ex-US Pharmacokinetic Study Of Its Oral Insulin For The Treatment Of Type 1 Diabetes
12/20/2013
-
Oramed Pharmaceuticals Inc. Receives Patent In The European Union For the Oral Delivery of Insulin
11/19/2013